Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
An. bras. dermatol ; 91(6): 811-814, Nov.-Dec. 2016. graf
Article in English | LILACS | ID: biblio-837979

ABSTRACT

Abstract Bacillary angiomatosis is an infection determined by Bartonella henselae and B. quintana, rare and prevalent in patients with acquired immunodeficiency syndrome. We describe a case of a patient with AIDS and TCD4+ cells equal to 9/mm3, showing reddish-violet papular and nodular lesions, disseminated over the skin, most on the back of the right hand and third finger, with osteolysis of the distal phalanx observed by radiography. The findings of vascular proliferation with presence of bacilli, on the histopathological examination of the skin and bone lesions, led to the diagnosis of bacillary angiomatosis. Corroborating the literature, in the present case the infection affected a young man (29 years old) with advanced immunosuppression and clinical and histological lesions compatible with the diagnosis.


Subject(s)
Humans , Male , Young Adult , Angiomatosis, Bacillary/pathology , AIDS-Related Opportunistic Infections/pathology , Biopsy , Ceftriaxone/therapeutic use , Treatment Outcome , Angiomatosis, Bacillary/drug therapy , AIDS-Related Opportunistic Infections/drug therapy , Azithromycin/therapeutic use , Bartonella henselae , Cancellous Bone/pathology , Anti-Bacterial Agents/therapeutic use
2.
Rev. méd. Chile ; 140(7): 910-914, jul. 2012. ilus
Article in Spanish | LILACS | ID: lil-656364

ABSTRACT

Background: Bacillary angiomatosis is an unusual infectious disease, with angioproliferative lesions, typical of immunocompromised patients. It is caused by Bartonella quintana and Bartonella henselae, two infectious agents of the genus Bartonella, which trigger variable clinical manifestations, including cutaneous vascular and purpuric lesions, and regional lymphadenopathy, and even a systemic disease with visceral involvement. We report a 38-year-old HIV positive male presenting with a history of six months of cutaneous growing purple angiomatous lesions, located also in nasal fossae, rhi-nopharynx and larynx. The skin biopsy was compatible with bacillary angiomatosis. Polymerase chain reaction of a tissue sample showed homology with B. quintana strain Toulouse. The patient was treated with azithromycin and ciprofloxacin with a favorable evolution.


Subject(s)
Adult , Humans , Male , AIDS-Related Opportunistic Infections/pathology , Angiomatosis, Bacillary/pathology , Bartonella quintana , AIDS-Related Opportunistic Infections/drug therapy , Angiomatosis, Bacillary/drug therapy , Anti-Bacterial Agents/therapeutic use , Azithromycin/therapeutic use , Biopsy , Ciprofloxacin/therapeutic use
3.
Rev. Soc. Bras. Med. Trop ; 44(5): 641-643, Sept.-Oct. 2011. ilus
Article in English | LILACS | ID: lil-602912

ABSTRACT

It is a report of disseminated bacillary angiomatosis (BA) in a 23-year-old female patient, who is HIV-positive and with fever, weight loss, hepatomegaly, ascites, and papular-nodular skin lesions. The clinical and diagnostic aspects involved in the case were discussed. Bacillary angiomatosis must always be considered in the diagnosis of febrile cutaneous manifestations in AIDS.


Relato de angiomatose bacilar (AB) disseminada em paciente do sexo feminino de 23 anos, HIV positiva, com febre, emagrecimento, hepatomegalia, ascite e lesões de pele pápulo-nodulares. Foram discutidos os aspectos clínicos e diagnósticos envolvidos no caso. Angiomatose bacilar deve sempre ser considerada no diagnóstico de doença febril com manifestações cutâneas na AIDS.


Subject(s)
Female , Humans , Young Adult , AIDS-Related Opportunistic Infections/diagnosis , Angiomatosis, Bacillary/diagnosis , AIDS-Related Opportunistic Infections/drug therapy , Angiomatosis, Bacillary/drug therapy , Erythromycin/therapeutic use , Gentamicins/therapeutic use
6.
Bol. Asoc. Méd. P. R ; 87(7/9): 140-146, Jul.-Sept. 1995.
Article in English | LILACS | ID: lil-411548

ABSTRACT

Bacillary angiomatosis is known to be caused by a rickettsial organism; Rochalimaea henselae. This causative agent has been compared with different microorganisms and clinical conditions that appear in similar settings buy have been clearly differentiated from them; e.i. Cat-scratch disease (Afipia felis), Bartonella bacilliformis, other Rochalimaea sp., Kaposi's sarcoma, Lobular capillary hemangioma, Angiosarcoma, and Epithelioid hemangioma. Clinically the bacillary angiomatosis (BA) skin lesions vary from a single lesion to thousands. The cutaneous lesion appears as a bright-red round papule, subcutaneous nodule, or as a cellulitic plaque. When the lesion is biopsied it tends to blanch-out, bleed, and cause pain. The patient might present with signs and symptoms of chills, headaches, fever, malaise, and anorexia with or without weight loss. The extracutaneous lesions found in BA tend to be from multiple organs affecting from the oral lesions to anal mucosal lesions to widespread visceral lesions. The sites of preference for BA lesion manifestation tend to be the liver, spleen, lymph nodes, and bone. To diagnose bacillary angiomatosis the physician should prepare a differential diagnosis based primarily on its histopathological and clinical characteristics. To confirm the results from the stain, electron microscopy can identify the bacillus and pin-point the diagnosis of bacillary angiomatosis. The lesions presented by BA respond well to therapy with erythromycin 500 mg four times daily for a duration of 2 weeks to 2 months. In case of intolerance to erythromycin the second line of drug that successfully treats the BA bacillus is doxycyline. If relapses of the BA lesion recur, then a prolonged antibiotic therapy is necessary and in AIDS patients the duration may be extended as life-long suppressive therapy


Subject(s)
Humans , Angiomatosis, Bacillary , Anti-Bacterial Agents/administration & dosage , Anti-Bacterial Agents/therapeutic use , Angiomatosis, Bacillary/diagnosis , Angiomatosis, Bacillary/drug therapy , Diagnosis, Differential , Doxycycline/administration & dosage , Doxycycline/therapeutic use , Erythromycin/administration & dosage , Erythromycin/therapeutic use , Sarcoma, Kaposi/diagnosis , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL